The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Persistence of Ebola Virus in Ocular Fluid during Convalescence
Open accessAbstract
Summ a r yAmong the survivors of Ebola virus disease (EVD), complications that include uveitis can develop during convalescence, although the incidence and pathogenesis of EVD-associated uveitis are unknown.We describe a patient who recovered from EVD and was subsequently found to have severe unilateral uveitis during convalescence.Viable Zaire ebolavirus (EBOV) was detected in aqueous humor 14 weeks after the onset of EVD and 9 weeks after the clearance of viremia.T he current outbreak of EVD is believed to have begun in December 2013. 1 As of April 26, 2015, a total of 26,312 cases of EVD (including 10,899 deaths) had been reported in six countries in West Africa (i.e., Sierra Leone, Liberia, Guinea, Mali, Nigeria, and Senegal), the United States, the United Kingdom, and Spain. 2 The outbreak has also resulted in the largest number of EVD survivors in history.Among survivors of EVD, late complications that include ocular disease can develop during convalescence.3,4 However, few systematic studies have been conducted on post-EVD sequelae, so the incidence and clinical manifestations of post-EVD ocular complications are unclear.Here, we report the clinical course of a man in whom severe, acute, unilateral uveitis developed during the convalescent phase of EVD.We also report the detection of viable EBOV in aqueous humor obtained from the inflamed eye 14 weeks after the onset of the initial symptoms of EVD and 9 weeks after the clearance of viremia. C a se R eportA previously healthy 43-year-old male physician received a diagnosis of EVD on September 6, 2014, while he was working in an Ebola treatment unit in Kenema, Sierra Leone.He was transferred to Emory University Hospital in Atlanta and arrived 4 days after the onset of symptoms.He was treated with an experimental small interfering RNA antiviral agent (TKM-100802, Tekmira Pharmaceuticals), convalescent plasma, and aggressive supportive care.5 The hospital course was complicated by multiorgan system failure requiring mechanical ventilation for 12 days and hemodialysis for 24 days.6 After extubation, the patient had altered mental status, difficulty walking related to severe proximal From the Department of Medicine, Division of Infectious Diseases (J.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
Gire, S. K., Goba, A., Andersen, K. G., Sealfon, R. S. G., Park, D. J., Kanneh, L., Jalloh, S., Momoh, M., Fullah, M., Dudas, G., et al. (2014) · Science · doi:10.1126/science.1259657 · Cited by 1,215
Rowe, A. K., Bertolli, J., Khan, A. S., Mukunu, R., Muyembe‐Tamfum, J. J., Bressler, D., Williams, A. J., Peters, C. J., Rodriguez, L., Feldmann, H., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514318 · Cited by 387
Outbreake of Marburg virus disease in Johannesburg
Gear, J. S., Cassel, G. A., Gear, A. J., Trappler, B., Clausen, L., Meyers, A. M., Kew, M. C., Bothwell, T. H., Sher, R., Miller, G. B., et al. (1975) · BMJ · doi:10.1136/bmj.4.5995.489 · Cited by 352
Rodriguez, L. L., De Roo, A., Guimard, Y., Trappier, S. G., Sanchez, A., Bressler, D., Williams, A. J., Rowe, A. K., Bertolli, J., Khan, A. S., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514291 · Cited by 311
Kraft, C. S., Hewlett, A. L., Koepsell, S., Winkler, A. M., Kratochvil, C. J., Larson, L., Varkey, J. B., Mehta, A. K., Lyon, G. M., Friedman-Moraco, R. J., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ334 · Cited by 195
Self-citationKibadi, K., Mupapa, K., Kuvula, K., Massamba, M., Ndaberey, D., Muyembe‐Tamfum, J. J., Bwaka, M. A., Roo, A. D., & Colebunders, R. (1999) · The Journal of Infectious Diseases · doi:10.1086/514288 · Cited by 134
Successful Delivery of RRT in Ebola Virus Disease
Connor, M. J., Jr., Kraft, C. S., Mehta, A. K., Varkey, J. B., Lyon, G. M., Crozier, I., Ströher, U., Ribner, B. S., & Franch, H. A. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111057 · Cited by 78
Self-citationUveal involvement in Marburg virus disease.
Kuming, B. S., & Kokoris, N. (1977) · British Journal of Ophthalmology · doi:10.1136/bjo.61.4.265 · Cited by 44
Cited by
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V., Siegel, D., Perron, M., Bannister, R., Hui, H. C., et al. (2016) · Nature · doi:10.1038/nature17180 · Cited by 1,556
Lee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
“With similar findings, the Ad26-ZEBOV/MVA-BN-Filo vaccine advanced from phase I trials in the UK in 2013 prior to the West African outbreak, with subsequent phase II and III studies relocated to West Africa upon the outbreak in 2014.(189,204,205) And though this vaccine has demonstrated rapid and durable protection ag…”
ResultAssessing the Gold Standard — Lessons from the History of RCTs
Bothwell, L. E., Greene, J. A., Podolsky, S. H., & Jones, D. S. (2016) · New England Journal of Medicine · doi:10.1056/nejmms1604593 · Cited by 664
Jacob, S. T., Crozier, I., Fischer, W. A., Hewlett, A., Kraft, C. S., Vega, M.-A. D. L., Soka, M. J., Wahl, V., Griffiths, A., Bollinger, L., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0147-3 · Cited by 664
Self-citationMolecular Evidence of Sexual Transmission of Ebola Virus
Mate, S. E., Kugelman, J. R., Nyenswah, T. G., Ladner, J. T., Wiley, M. R., Cordier-Lassalle, T., Christie, A., Schroth, G. P., Gross, S. M., Davies-Wayne, G. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509773 · Cited by 434
Self-citation
Metadata
- Authors
- Varkey, J. B., Shantha, J. G., Crozier, I., Kraft, C. S., Lyon, G. M., Mehta, A. K., Kumar, G., Smith, J. R., Kainulainen, M. H., Whitmer, S., Ströher, U., Uyeki, T. M., Ribner, B. S., & Yeh, S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-06-18
- Volume
- 372
- Issue
- 25
- Pages
- 2423-2427
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W277041599
- Cited by
- 470
- References
- 8
- FWCI
- 59.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.